• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

The Uphill Task of Enrollment in Private Exchanges

Article

At a webinar convened by AISHEalth, "Private Exchange Strategies: What's Working Today? What's Next?" Ashish Kaura and Jay Godla, both partners with Strategy&, provided insight into the challenges faced by private exchanges.

Starwood Hotels & Resorts Worldwide Inc.’s recent announcement it would shift 26,000 US staff and their dependents to Towers Watson & Co.’s One Exchange demonstrates private health insurance exchanges’ continuing success at attracting employers with the promise of cost savings and more choice for employee benefit decision-making.

But the growth in these marketplaces will only meet robust expectations of many in the industry if and when employers can count on sustainable cost reduction. This will likely happen over the next five years, according to Ashish Kaura and Jay Godla, both partners with Strategy&, who spoke on April 21 at the AIS webinar, “Private Exchange Strategies: What’s Working Today? What’s Next?”

Working off the premise that the market is still in a learning phase, the pair said large employers especially are trying to figure out which, if any, exchange model offers the right strategy and real cost savings. Exchanges already offer employers a selection of health plan product designs and “pre-shopping” or product set-up services, Godla said. Employees are also able, through a multi-carrier or single-carrier exchange contracted by their employer, to buy coverage and enroll.

Read the complete article on AISHEalth: http://bit.ly/1E8yAJY

Related Videos
Eric Levin, Scripta
Jennifer Snow, MPA, NAMI
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Dr Marco Del Riccio
Dr Steven Manobianco
Tom Kim, chief medical officer, Sound Long-Term Care Management
Dr Yara Abdou
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.